We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

Bone Health · 6 min read

Bone health, osteoporosis, and menopause

By Kevin Wolfe, Founder & CEO

Reviewed by Kindr Health Clinical Team

Published · Updated

Bone loss accelerates sharply at menopause. Estrogen, strength training, and adequate protein are the fundamentals.

In the 5 years following the final period, women lose roughly 10–20% of bone mineral density. This is the single most under-discussed long-term consequence of estrogen loss, and it is the slow-moving driver of the hip fractures that follow decades later.

What protects bone

  • Estrogen therapy — the single most effective intervention if started in the early postmenopausal window
  • Resistance training 3–4× weekly with progressive load
  • 1.2–1.6 g/kg/day of protein
  • 1000–1200 mg calcium daily, ideally from food
  • 800–2000 IU vitamin D, dose-adjusted by lab

When to screen

A baseline DEXA scan is appropriate within the first few years of menopause for most women, and earlier for those with risk factors (low BMI, family history, steroid use, smoking).

Sources

Medically reviewed by Kindr Health Clinical Team
Last updated: May 10, 2026

More on long-term midlife health

Continue across the Kindr entity graph

Related evidence, peptides, and clinical tools on the same topic.

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Keep reading

Research

Who shouldn't take hormone therapy? Contraindications, gray areas, and your non-hormonal options.

A recent conference presentation found that hormone therapy prescribing despite a documented contraindication is rising in primary care. Here's what current FDA labels list as contraindications, where an individualized discussion comes in, and which nonhormonal options a major guideline suggests.

Research

Is there an age limit on hormone therapy? Timing, the 10-year window, and HT after 60 and 65.

A SWAN analysis and current FDA and ACOG guidance frame hormone therapy around timing and individual history, not a single age cutoff. Here's what that means for starting, continuing after 60 or 65, and what to ask a clinician.

Research

Strong through menopause: why muscle matters, especially if you're on a GLP-1

A trial of 120 midlife adults on tirzepatide found that lifting three times a week reduced lean-tissue loss and raised strength, with similar weight loss. Here's what that means if you're navigating menopause, and what to discuss with your clinician before you start.

Explore your next step

Kindr Care is being updated, and the exact clinical process will depend on the current care pathway.

Explore care options →